| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 95.7824 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 116.858 | 77 |
| GSM780709 | Untreated after 4 days (C3_1) | 108.611 | 76 |
| GSM780719 | Untreated after 4 days (C1_2) | 82.837 | 72 |
| GSM780720 | Untreated after 4 days (C2_2) | 107.117 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 97.4295 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 141.963 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 109.089 | 76 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 70.6137 | 69 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 98.4528 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 98.3558 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 71.4188 | 69 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 71.2152 | 69 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 91.7609 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 87.1352 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 74.706 | 70 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 78.4249 | 71 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 79.3015 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 163.568 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 152.722 | 81 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 176.631 | 82 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 153.951 | 81 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 127.266 | 78 |